IDC:小米(01810.HK)第三季可穿戴設備穩坐內地市場首位
國際數據公司(IDC)發表《中國可穿戴設備市場季度跟蹤報告,2019年第三季度》顯示,2019年第三季度中國可穿戴設備市場出貨量為2,715萬台,按年增長 45.2%。基礎可穿戴設備(不支持第三方應用的可穿戴設備)出貨量為2,097萬台,按年增長38.2%,智能可穿戴設備出貨量為618萬台,同比增長75.5%。
小米手環4作為新一代產品,憑藉優化的產品體驗和極具競爭力的市場價格,本季度大規模出貨,幫助小米(01810.HK)穩坐市場第一的位置。華為依然是本季度同比增長速度最快的廠商,新推出的手環4e和兒童手錶幫助其實現同環比雙增長。蘋果手錶和耳機均呈顯著增長趨勢,助其獲取更多市場份額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.